Author
Listed:
- Zameer Shervani
(Food Energy Security Research Product Centre, Sendai, Japan INTI International University, Putra Nilai, Malaysia)
- Aamir Akbar Khan
(Ross University School of Medicine, Miramar, USA.)
- Intazam Khan
(Progressive Neurology-Astoria, New York, USA)
- Shagufta Nazneen Ansari
(Integral University, Lucknow, India)
- Deepali Bhardwaj
(Centre for Skin and Hair Pvt. Ltd., New Delhi, India)
- Diwakar Madan Kumar
(Ragas Dental College and Hospital, Chennai, India)
- Akram Mohammad
(Department of Earth and Environment Sciences, University of Ottawa, Ottawa, Canada)
Abstract
The novel coronavirus (SARS-CoV-2) caused a large number of deaths during the COVID-19 pandemic. The pandemic had a greater impact on wealthy and developed countries. Considering the per capita deaths and fatality-to-case ratio, also known as the case fatality ratio (CFR), Japan was among the least affected countries. The CFR of Japan was compared with nine other democratic and wealthy countries: the US, Italy, Spain, France, Austria, Germany, Canada, Australia, and South Korea. Japan’s CFR was the second lowest at 0.2%, only behind South Korea with 0.1%. The highest rates were recorded by the US and Canada, each at 1.1%. The per capita (per 100,000 people) fatality rate of Japan was 57.72 deaths, whereas the US had six times more deaths compared to Japan. We calculated the mortality (fatality) rates based on the cumulative deaths as of March 16, 2023, when the pandemic was mostly over. The amount of GDP spent on healthcare in Japan, mask awareness, the stringency index (SI), vaccinations, urbanization, life expectancy (LE), and the age cohorts of the population were examined to determine the factors that resulted in a low mortality rate in Japan during the pandemic.
Suggested Citation
Zameer Shervani & Aamir Akbar Khan & Intazam Khan & Shagufta Nazneen Ansari & Deepali Bhardwaj & Diwakar Madan Kumar & Akram Mohammad, 2025.
"Factors Explaining Japan’s Low COVID-19 Mortality: Comparison with Rich and Democratic Countries,"
European Journal of Medical and Health Sciences, European Open Science, vol. 7(1), pages 1-9, January.
Handle:
RePEc:epw:ejmed0:v:7:y:2025:i:1:id:42245
DOI: 10.24018/ejmed.2025.7.1.2245
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:ejmed0:v:7:y:2025:i:1:id:42245. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support (email available below). General contact details of provider: https://eu-opensci.org/index.php/ejmed .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.